Editor's Note ECRI announced October 21 that its President and CEO, Marcus Schabacker, MD, PhD, will tell the Food & Drug Administration Vaccines and Related Biological Products Advisory Committee on October 22 that a thorough review of 6 months of completed clinical trial data for COVID-19 vaccines is needed to…

Read More

Editor's Note A Kaufman Hall survey released October 19 finds that nearly 75% of hospital executives are “extremely” or “moderately” worried about their organizations’ financial viability without a COVID-19 vaccine. One third say year-over-year operating margins dropped more than 100% in the second quarter. The only specialty area that a…

Read More

Editor's Note This international, multicenter study finds that dedicated COVID-19-free surgical pathways should be established to provide safe elective cancer surgery during the pandemic. Researchers from more than 130 countries examined data on 9,171 patients in 55 countries from the start of the pandemic to the middle of April 2020.…

Read More

Editor's Note The Food and Drug Administration (FDA) on October 6 released guidance on the data and information needed to support the issuance of emergency use authorization (EUA) for COVID-19 vaccines. The recommended data and information include: chemistry, manufacturing, and controls information clinical and nonclinical data and information administration and…

Read More

Editor's Note This survey by researchers at the University of Minnesota, Minneapolis, between April 23 and 27, finds the public’s preferences for allocating a COVID-19 vaccine consistent with experts’ recommendations that offer vaccine priority to groups defined by age, risk of dying, and employment type. Of 1,007 American adults surveyed:…

Read More

Editor's Note Preliminary findings in Moderna’s (Cambridge, Massachusetts) COVID-19 trial show the vaccine elicits strong immune system responses in older adults similar to responses in younger recipients, and adverse events associated with the vaccine are mainly mild or moderate. In its expansion to include older adults, the trial enrolled 40…

Read More

Editor's Note The American Hospital Association (AHA) announced September 26 that it has launched a new webpage that comprises AHA-developed tools and resources from the federal government and others related to COVID-19 vaccines. The AHA will update the webpage often as new developments occur to keep the healthcare field informed…

Read More

Editor's Note The US Department of Health and Human Services (HHS) and Department of Defense (DOD) on September 16 released two documents outlining a detailed strategy for delivering safe and effective COVID-19 vaccine doses to the American people as quickly and reliably as possible. The documents, which were developed in…

Read More

Editor's Note Washington University School of Medicine in St Louis is the clinical coordinating center for a new worldwide clinical trial to test whether the vaccine for measles, mumps, and rubella (MMR) can protect frontline healthcare workers (HCWs) against COVID-19. The researchers say there are two main reasons why the…

Read More

Editor's Note In this study from Russia’s Gamaleya National Research Center for Epidemiology and Microbiology, researchers found that a heterologous COVID-19 vaccine based on recombinant human adenovirus type 26 (rAD26) and type 5 (rAD5) had a good safety profile over 42 days and induced strong antibody responses in all participants…

Read More